Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics Revenue

Guided Therapeutics had revenue of $767.00K in the twelve months ending March 31, 2026, up 76,600.00% year-over-year. In the year 2025, Guided Therapeutics had annual revenue of $767.00K with 10,857.14% growth.

• Revenue: 767.00K
• Revenue Growth: +76,600.00%
• P/S Ratio: 28.70
• Revenue / Employee: 255.67K
• Employees: 3
• Market Cap: 22.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	767.00K	760.00K	10,857.14%
Dec 31, 2024	7.00K	-91.00K	-92.86%
Dec 31, 2023	98.00K	85.00K	653.85%
Dec 31, 2022	13.00K	-68.00K	-83.95%
Dec 31, 2021	81.00K	-21.00K	-20.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error